1. Vasodilating and alphareceptor blocking activity of a new ergoline derivative;Arcari, G.; Dosignotti, L.; Fregnan, G.B.; Glasser, A.H.;British Journal of Pharmacology,1968
2. Action of Lysergide, Ephedrine and Nimergoline on brain metabolizing activity;Benzi, G.; Manzo, L.; De Bemardi, M.; Ferrara, A.; Sanguinetti, L.; Assigoni, E.; Beste, F.;Journal of Pharmaceutical Sciences,1971
3. Regional cerebral blood flow in man determined by the initial slope of the clearance of intraarterially injected 133Xe;Stroke,1971
4. Variations in mean cerebral blood flow under anaesthesia at rest and during cortical activation;Palmer, N.I.; Thomas, D.J.; MacGillivray, B.B.; Du Boulay, G.H.; Marshall, J.; Ross Russell, R.; Symon, L.;Stroke,1977
5. Wilkinson, I. M. S., Bull, J. W. D., Du Boulay, G. H., Marshall, J., Ross Russell, R., and Symon, L. (1969).